Practice Changing Publications: Expert Panel Discussion 05-24-2023
Publication/Article
Improved Overall Survival of Melanoma of the Head and Neck Treated with Mohs Micrographic Surgery versus Wide Local Excision
Citation: Hanson J, Demer A, Liszewski W, Forman N, Maher I. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision. J Am Acad Dermatol. 2020 Jan;82(1):149-155
Date/Time
Wednesday, May 24, 2023 | 7:00-8:00 pm Central
Description
This webinar will cover improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision. It will start with a summary of key, clinically impactful concepts from the publication, followed by an expert panel point-counterpoint discussion.
Learning Objectives
Following this activity, participants should be able to:
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation. Credit is provided for live webinar attendees.
Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Improved Overall Survival of Melanoma of the Head and Neck Treated with Mohs Micrographic Surgery versus Wide Local Excision
Citation: Hanson J, Demer A, Liszewski W, Forman N, Maher I. Improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision. J Am Acad Dermatol. 2020 Jan;82(1):149-155
Date/Time
Wednesday, May 24, 2023 | 7:00-8:00 pm Central
Description
This webinar will cover improved overall survival of melanoma of the head and neck treated with Mohs micrographic surgery versus wide local excision. It will start with a summary of key, clinically impactful concepts from the publication, followed by an expert panel point-counterpoint discussion.
Learning Objectives
Following this activity, participants should be able to:
- Recognize the scenarios where CCPDMA can improve outcomes in the treatment of melanoma.
- Describe the situations where CCPDMA has not demonstrated improved outcome.
- Summarize the relative risks and costs associated with various settings and procedures for the treatment of melanoma.
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit in your ASDS Learn profile and download your CME certificate, you will need to view the webinar and complete the attendee evaluation. Credit is provided for live webinar attendees.
Accreditation Statement
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Presenters
Ian Maher, MD
Faculty / Author
Dr. Maher is a board-certified dermatologic surgeon who treats adult patients with basal and squamous cell carcinoma, melanoma and skin cancer. He specializes in performing post-skin cancer reconstruction, skin flaps and grafts, mohs surgery and treating rare cutaneous malignancies.
Faculty / Author
Dr. Maher is a board-certified dermatologic surgeon who treats adult patients with basal and squamous cell carcinoma, melanoma and skin cancer. He specializes in performing post-skin cancer reconstruction, skin flaps and grafts, mohs surgery and treating rare cutaneous malignancies.
Addison Demer, MD
Faculty / Author
Dr. Demer is a board-certified dermatologic surgeon and serves as the Director of Derm Surgery Resident Education at Mayo Clinic College of Medicine and Science. His research and clinical interests include special-site cutaneous melanoma, high-risk non-melanoma skin cancer, and reconstruction.
Faculty / Author
Dr. Demer is a board-certified dermatologic surgeon and serves as the Director of Derm Surgery Resident Education at Mayo Clinic College of Medicine and Science. His research and clinical interests include special-site cutaneous melanoma, high-risk non-melanoma skin cancer, and reconstruction.
Chris Bichakjian, MD
Faculty / Expert Panelist
Dr. Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School. He has special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006, along with expertise in the field of cutaneous surgery and oncology.
Faculty / Expert Panelist
Dr. Bichakjian is professor of dermatology and chair of the Department of Dermatology at the University of Michigan Medical School. He has special interest in Merkel cell carcinoma and established one of the first multidisciplinary programs in the world for this rare skin cancer in 2006, along with expertise in the field of cutaneous surgery and oncology.
Christopher Miller, MD
Faculty / Expert Panelist
Dr. Miller is board-certified dermatologist in Philadelphia and is the director at Penn Dermatology Oncology Center. He specializes in Mohs micrographic surgery, reconstructive surgery, cutaneous oncology.
Faculty / Expert Panelist
Dr. Miller is board-certified dermatologist in Philadelphia and is the director at Penn Dermatology Oncology Center. He specializes in Mohs micrographic surgery, reconstructive surgery, cutaneous oncology.
David Brodland, MD
Faculty / Expert Panelist
David Brodland, MD, is a board-certified dermatologist who specializes in Mohs surgery. Among Dr. Brodland’s many accolades, he’s an assist professor at the University of Pittsburg and formerly served as the President of the American College of Mohs Surgery.
Faculty / Expert Panelist
David Brodland, MD, is a board-certified dermatologist who specializes in Mohs surgery. Among Dr. Brodland’s many accolades, he’s an assist professor at the University of Pittsburg and formerly served as the President of the American College of Mohs Surgery.
Copyright © 2023, ASDS. Copy and distributing content in print or any electronic forms without written permission from ASDS is strictly prohibited.
